FDA NDC Directory · JSON-LD · Markdown

Orbactiv

NDC 70842-140 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameoritavancin
Labeler / ManufacturerMelinta Therapeutics, LLC
Marketing categoryNew Drug Application (innovator) · App NDA206334
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsORITAVANCIN (400 mg/1)
Marketing started20140901
Package count1

External sources

Source: openFDA. Public-domain (CC0).